Orexigen Therapeutics Inc (NASDAQ:OREX)

Data as of Jan 23
 +0.13 / +2.46%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues1.2M4.4M3.4M3.4M
Depreciation And Amortization473.0K443.0K313.0K94.0K
Operating ExpensesGross Income--4.0M----
General Expenses52.2M31.8M93.4M80.5M
Research And Development25.1M12.8M73.7M56.7M
Total Operating Expenses52.6M32.3M93.7M80.6M
Non-Operating ExpensesOperating Income-51.4M-27.9M-90.2M-77.2M
Interest Expense On Debt644.0K221.0K2.0K538.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-51.9M-28.1M-90.1M-77.7M
Net Income-51.9M-28.1M-90.1M-77.7M
Shares To Calculate EPSShares To Calculate EPS47.4M48.3M70.7M96.5M
Shares To Calculate EPS Diluted47.4M48.3M70.7M96.5M
Earnings Per ShareEPS-$1.10-$0.58-$1.27-$0.80
EPS Diluted-$1.10-$0.58-$1.27-$0.80

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.